Haloperidol blood levels and clinical outcome: a meta-analysis of studies relevant to testing the therapeutic window hypothesis.

de Oliveira, I R; de Sena, E P; Pereira, E L; Miranda, A M; de Oliveira, N F; Ribeiro, M G; de Castro-e-Silva, E; Dardennes, R M; Samuel-Lajeunesse, B; Marcilio, C

de Oliveira, I R; de Sena, E P; Pereira, E L; Miranda, A M; de Oliveira, N F; Ribeiro, M G; de Castro-e-Silva, E; Dardennes, R M; Samuel-Lajeunesse, B; Marcilio, C.

Affiliation

de Oliveira IR; Department of Pharmacology and Physiology, Federal University of Bahia, Salvador-Bahia, Brazil.

J Clin Pharm Ther ; 21(4): 229-36, 1996 Aug.

Article in En | MEDLINE | ID: mdl-8933296

Subject(s)

Antipsychotic Agents/blood; Haloperidol/blood; Schizophrenia/blood; Analysis of Variance; Antipsychotic Agents/therapeutic use; Dose-Response Relationship, Drug; Haloperidol/therapeutic use; Humans; Psychiatric Status Rating Scales; Schizophrenia/drug therapy; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Haloperidol Type of study: Systematic_reviews Limits: Humans Language: En Journal: J Clin Pharm Ther Year: 1996 Document type: Article

Search on Google

XML

PubMed Links